<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226342/" ref="ordinalpos=4258&amp;ncbi_uid=3736539&amp;link_uid=PMC3226342" image-link="/pmc/articles/PMC3226342/figure/F2/" class="imagepopup">Figure 2. Proposed function of the EGFR in pituitary corticotrophs..  From: A new medical therapy for Cushing disease?. </a></div><br /><div class="p4l_captionBody">(<b>A</b>) Relationship between Pomc expression (which encodes a precursor protein that can be cleaved to generate ACTH) and pituitary cell growth mediated by the MAPK pathway. Corticotroph adenomas have aberrant MAPK pathway activation, resulting in pituitary cell growth and increased Pomc expression (4). (<b>B</b>) Use of a TKI reduces corticotroph adenoma growth and Pomc expression, which is mediated by the MAPK signaling pathway.    </div></div>